DYSLIPIDEMIA AND CARDIOVASCULAR RISK: FOCUS ON THE ROLE OF LOW HDL-CHOLESTEROL CONCENTRATIONS IN DEVELOPING ATHEROSCLEROTIC DISEASE AND IN ACCELERATING ITS PROGRESSION FROM SUBCLINICAL LESIONS TO CLINICAL EVENTS. EVIDENCES AND THERAPEUTICAL IMPLICATIONS.